Cephalon Sued For Delaying Generic Competition
Drug maker Cephalon Inc.'s attempts to stave off generic competition for its narcolepsy drug Provigil has landed it in the middle of a class action antitrust lawsuit, along with six of...To view the full article, register now.
Already a subscriber? Click here to view full article